Squarepoint’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.8M Buy
121,196
+66,586
+122% +$19.8M 0.04% 447
2025
Q4
$14.9M Sell
54,610
-41,172
-43% -$11.2M 0.02% 881
2025
Q3
$25.9M Buy
95,782
+21,935
+30% +$5.97M 0.03% 626
2025
Q2
$20.4M Buy
73,847
+19,170
+35% +$5.21M 0.02% 757
2025
Q1
$14.5M Sell
54,677
-5
-0% -$1.23K 0.02% 843
2024
Q4
$12.7M Sell
54,682
-56,011
-51% -$12.9M 0.01% 1011
2024
Q3
$24.4M Sell
110,693
-147,936
-57% -$30.6M 0.04% 507
2024
Q2
$50.8M Buy
258,629
+111,317
+76% +$23M 0.08% 227
2024
Q1
$31.7M Sell
147,312
-16,753
-10% -$3.52M 0.05% 415
2023
Q4
$34.6M Sell
164,065
-4,113
-2% -$878K 0.07% 332
2023
Q3
$33.7M Buy
168,178
+109,393
+186% +$21.7M 0.08% 265
2023
Q2
$10.9M Sell
58,785
-6,390
-10% -$1.18M 0.03% 620
2023
Q1
$12.5M Sell
65,175
-367,241
-85% -$66.4M 0.05% 455
2022
Q4
$72.7M Buy
432,416
+198,472
+85% +$34.5M 0.29% 51
2022
Q3
$41.4M Buy
233,944
+160,358
+218% +$31.7M 0.21% 85
2022
Q2
$15.1M Sell
73,586
-15,460
-17% -$3.28M 0.08% 271
2022
Q1
$21.2M Sell
89,046
-66,645
-43% -$15.7M 0.09% 226
2021
Q4
$35.6M Buy
155,691
+24,627
+19% +$5.42M 0.09% 188
2021
Q3
$25.3M Sell
131,064
-5,242
-4% -$1.06M 0.07% 242
2021
Q2
$29M Buy
136,306
+91,306
+203% +$19.3M 0.11% 168
2021
Q1
$9.19M Sell
45,000
-9,417
-17% -$1.85M 0.05% 392
2020
Q4
$9.91M Sell
54,417
-112,683
-67% -$19.2M 0.07% 257
2020
Q3
$28M Sell
167,100
-65,553
-28% -$11M 0.38% 43
2020
Q2
$37.8M Buy
232,653
+176,740
+316% +$31.7M 0.61% 8
2020
Q1
$9.67M Sell
55,913
-44,376
-44% -$8.83M 0.25% 84
2019
Q4
$20.1M Buy
100,289
+55,289
+123% +$11.3M 0.12% 142
2019
Q3
$9.51M Sell
45,000
-59,421
-57% -$12.4M 0.08% 297
2019
Q2
$20.3M Sell
104,421
-77,588
-43% -$14.3M 0.2% 117
2019
Q1
$30M Buy
182,009
+167,009
+1,113% +$29.5M 0.32% 63
2018
Q4
$2.82M Sell
15,000
-30,000
-67% -$5.54M 0.03% 570
2018
Q3
$7.66M Sell
45,000
-6,611
-13% -$1.11M 0.09% 290
2018
Q2
$8.46M Sell
51,611
-76,975
-60% -$12.6M 0.11% 274
2018
Q1
$20.8M Buy
128,586
+77,391
+151% +$12.3M 0.33% 71
2017
Q4
$7.48M Sell
51,195
-93,210
-65% -$13.3M 0.13% 174
2017
Q3
$19.6M Buy
144,405
+26,027
+22% +$3.29M 0.38% 54
2017
Q2
$14.8M Sell
118,378
-36,588
-24% -$4.38M 0.29% 70
2017
Q1
$18.4M Buy
154,966
+115,157
+289% +$13.8M 0.51% 27
2016
Q4
$4.59M Buy
39,809
+16,328
+70% +$1.82M 0.19% 118
2016
Q3
$2.45M Buy
+23,481
New +$2.45M 0.16% 150
2016
Q2
Sell
-9,812
Closed -$942K 1126
2016
Q1
$942K Sell
9,812
-20,188
-67% -$1.84M 0.07% 403
2015
Q4
$2.72M Buy
+30,000
New +$2.82M 0.3% 49
2015
Q3
Sell
-2,334
Closed -$217K 434
2015
Q2
$217K Buy
+2,334
New +$218K 0.07% 359

Other funds holding CME

Squarepoint's CME Position: Q1 2026 in Review

Squarepoint increased its CME Group (CME) stake by 122% in Q1 2026, buying an estimated $19.8M and bringing the position to 121,196 shares worth $35.8M. The position accounts for 0.04% of the portfolio, ranked #447.

Squarepoint first reported a position in CME in Q2 2015 and has held it in 42 quarters since. The position peaked at $72.7M in Q4 2022. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Squarepoint held 121,196 shares of CME Group worth $35.8M as of Q1 2026.
  • Squarepoint bought 66,586 CME Group shares in Q1 2026, an estimated $19.8M.
  • CME Group made up 0.04% of Squarepoint's portfolio in Q1 2026, its #447 holding.
  • Squarepoint first reported a position in CME Group in Q2 2015 and has held it in 42 quarters since.
  • Squarepoint's CME Group position peaked at $72.7M in Q4 2022.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.